Revance Therapeutics Inc (NAS:RVNC)
$ 3.25 -0.14 (-4.13%) Market Cap: 339.27 Mil Enterprise Value: 638.64 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 58/100

Revance Therapeutics Inc (RVNC) Transcripts

  • 1